Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
PD 173952 is a multi-kinase inhibitor.1,2 It inhibits LYN, Abl, CSK, and c-Src in cell-free assays (IC50s = 0.3, 1.7, 6.6, and 8.5 nM, respectively. PD 173952 inhibits the growth of HCT-8, SW620, and HT-29 colon carcinoma cells (IC50s = 1.53, 1.8, and 0.526 µM, respectively).1 It induces cell cycle arrest at the G2/M phase in HT-29 cells when used at a concentration of 1 µM. PD 173952 (0.5 µM) induces apoptosis in K562 and MEG-01 chronic myeloid leukemia cells.2 It also inhibits ristocetin-induced aggregation in human platelet-rich plasma.3
WARNING This product is not for human or veterinary use.
1. Biochemical and cellular effects of c-
2. Interleukin-
3. GPIb-